HCFA's Handling Of NPPV Device Payment Questioned By House Panel
This article was originally published in The Gray Sheet
Executive Summary
The House Commerce Committee is asking the Health Care Financing Administration to explain why the agency believes that non-invasive positive pressure ventilation (NPPV) devices should be placed in the capped rental payment category.
You may also be interested in...
Industry Opposition To NPPV Payment Reclassification Proposal Aired
HCFA will likely go ahead with its proposed reclassification of the durable medical equipment (DME) payment category for non-invasive positive pressure ventilation devices (NPPVs), despite industry opposition voiced at a recent public meeting in Baltimore on Medicare payments for respiratory assist devices.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.